Professor of Medicine, University KY College of Medicine

Pulmonology

Dr. Dennis E. Doherty, MD

Dennis Doherty works in the field of Pulmonology. He graduated from The Ohio State University College of Medicine. He has 1 awards "America's Top Doctors". Dennis Doherty is a published MD as well. He has 39 publications published. The latest was: Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

Publications

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.
Oxygen therapy in advanced COPD: in whom does it work?
A review of the role of FEV1 in the COPD paradigm.
Documentation of airflow obstruction is essential to confirm the diagnosis of COPD: are handheld spirometers in an office setting valid?
The value of early diagnosis for effective management of Chronic obstructive pulmonary disease.
Acute alcohol intake impairs Lung inflammation by changing pro- and anti-inflammatory mediator balance.
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
Recommendations of the 6th long-term oxygen therapy consensus conference.
The pathophysiology of airway dysfunction.
Efficient identification and use of tumor-associated antibodies as markers of non-small cell Lung cancer.
Improving COPD management in the nursing home--part 2.
Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis.
Long-term pharmacologic management of patients with Chronic obstructive pulmonary disease.
Long-term nonpharmacologic management of patients with Chronic obstructive pulmonary disease.
TNF-alpha-dependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii.
Identification and assessment of Chronic obstructive pulmonary disease in the elderly.
Empyema caused by trichomonas.
Management of the symptomatic patient.
Improving COPD management in the nursing home--Part 1.
Early detection and management of COPD. What you can do to reduce the impact of this disabling disease.
Induction of cyclo-oxygenase-2 in non-small cell Lung cancer cells by adenovirus vector information.
Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell Lung cancer (NSCLC).
Antibodies to HSP70 and HSP90 in serum in non-small cell Lung cancer patients.
Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell Lung cancer.
Large-scale gene profiling of the liver in a mouse model of Chronic, intragastric ethanol infusion.
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.
[Assessing the prognosis in patients with Chronic obstructive pulmonary disease].
The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort.
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from poole...
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III ...
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Pha...
Comparison of the Asthma in America and Asthma Insight and Management surveys: Did asthma burden and care improve in the United States between 1998 and 2009?
Patient and physician asthma deterioration terminology: Results from the 2009 Asthma Insight and Management survey.
Asthma burden in the United States: Results of the 2009 Asthma Insight and Management survey.
Asthma management and control in the United States: Results of the 2009 Asthma Insight and Management survey.
Montelukast added to fluticasone propionate does not alter inflammation or outcomes.
Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.
The National Lung Health Education Program: roots, mission, future directions.

Schools

Ohio State University College of Medicine
Ohio State University Hosps
Ohio State University Hospital
University Colo Health Science Center

Conditions Treated

COPD (Chronic Obstructive Pulmonary Disease)
Lung Cancer
Pulmonary Hypertension
Sarcoidosis
View All

Doctors Specialties

Pulmonology

Accepted Insurances

Awards

America's Top Doctors

Education

University of Colorado
Ohio State University Hospital
The Ohio State University College of Medicine

Drug Facts

NPI NUMBER		1750391777
NPPES Provider LastName		DOHERTY
NPPES Provider FirstName		DENNIS
NPPES Provider ZIPCode		310249580
NPPES Provider State		GA
Specialty Description		Pain Management
Total Claim Count		1783.0
Distinct Opioid Count		12.0
Opioid Claim Count		830.0
Percent Opioid Claims		46.55

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1750391777
Last Name Of The Provider	DOHERTY
First Name Of The Provider	DENNIS
View All

Similar Doctors

	Dr. Byron T. Westerfield, MD This Doctor is OpenDoctor Recommended.
	Dr. Grant H. Breazeale, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas M. Jarboe, MD This Doctor is OpenDoctor Recommended.
	Dr. Alexander E. Tzouanakis, MD This Doctor is OpenDoctor Recommended.
	Dr. Bruce C. Broudy, MD This Doctor is OpenDoctor Recommended.
	Dr. David M. Mannino III, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ryan C. Kamp, MD This Doctor is OpenDoctor Recommended.
	Dr. Hyeong J. Kim, MD
	Dr. Edward A. Hirschowitz, MD This Doctor is OpenDoctor Recommended.
	Dr. Steve S. Kraman, MD This Doctor is OpenDoctor Recommended.
	Olufunsho Bankole
	Dr. Wheeler J. Dale, MD This Doctor is OpenDoctor Recommended.